Fig. 2From: Nanotechnology in leukemia: diagnosis, efficient-targeted drug delivery, and clinical trialsB-cell receptor signaling inhibitors. BCR: B cell receptor; BTK: Bruton’s tyrosine kinase; SYK: spleen tyrosine kinase; BLNK: B-cell linker; PLCγ2: phospholipase Cγ2; PI3K: phosphoinositide 3-kinase, the “P” in blue circle indicates phosphorylation, LYN: a gene on chromosome 8q13 that encodes a non-receptor tyrosine protein kinase, AKT: serine/threonine kinaseBack to article page